Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia.
暂无分享,去创建一个
Michael J Owen | Nadine Norton | Nigel M Williams | Vahram Haroutunian | M. Owen | J. Buxbaum | V. Moskvina | V. Haroutunian | N. Williams | N. Norton | M. O’Donovan | N. Bray | T. Peirce | Joseph D Buxbaum | Nicholas J Bray | Valentina Moskvina | Michael C O'Donovan | Timothy R Peirce | Anna Preece | A. Preece | Anna C Preece
[1] S. Antonarakis,et al. Nomenclature for the description of human sequence variations , 2001, Human Genetics.
[2] Philip D. Harvey,et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.
[3] J. Wolff,et al. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: A membrane-bound, microtubule-associated protein and membrane anchor for tubulin , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] Jurg Ott,et al. Handbook of Human Genetic Linkage , 1994 .
[5] B. Devlin,et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. , 2002, Human molecular genetics.
[6] Michael Owen,et al. Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools , 2000, Human Genetics.
[7] J. Kelsoe,et al. Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. , 2000, Physiological genomics.
[8] M. Owen,et al. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. , 2003, American journal of human genetics.
[9] L. Jones,et al. Comparative sequencing of the proneurotensin gene and association studies in schizophrenia , 2000, Molecular Psychiatry.
[10] P. Sham,et al. Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.
[11] Michael C O'Donovan,et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.
[12] M. Owen,et al. Cis-acting variation in the expression of a high proportion of genes in human brain , 2003, Human Genetics.
[13] K. Nave,et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.
[14] M. Owen,et al. Genome scans and microarrays: converging on genes for schizophrenia? , 2002, Genome Biology.
[15] J. Kelsoe,et al. Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder , 2003, Molecular Psychiatry.
[16] W H Wong,et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Ward,et al. Haplotypic analysis of the TNF locus by association efficiency and entropy , 2003, Genome Biology.
[18] D. Lewis,et al. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.
[19] C. Aston,et al. Microarray analysis of postmortem temporal cortex from patients with schizophrenia , 2004, Journal of neuroscience research.
[20] H. Stefánsson,et al. Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.
[21] W. Honer,et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins , 2003, Molecular Psychiatry.
[22] Peter B. Jones,et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.
[23] G. Kirov,et al. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools , 2002, Human Genetics.
[24] T. Brugha,et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. , 1990, Archives of general psychiatry.
[25] M. O’Donovan,et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. , 1999, Clinical chemistry.